Recruiting

Post Exacerbation Asthma Clinic Telecare Intervention to Reduce Recurrent Exacerbations

Asthma exacerbations leading to emergency department visits or hospitalization are associated with a high risk of recurrent exacerbations, poor disease control, and increased healthcare utilization in the months following discharge. Early specialist follow-up during this vulnerable transition period remains limited, and many patients do not receive optimized long-term asthma management. The purpose of this study is to evaluate whether a structured remote asthma clinic intervention initiated shortly after hospital…

ClinicalTrials.gov IDNCT07629830
PhaseNA
Enrollment220
SponsorTel-Aviv Sourasky Medical Center
Age18 Years
SexALL
I'm interested View official listing

Conditions studied

Asthma Acute, Asthma Attack

About this study

Asthma exacerbations leading to emergency department visits or hospitalization are associated with a high risk of recurrent exacerbations, poor disease control, and increased healthcare utilization in the months following discharge. Early specialist follow-up during this vulnerable transition period remains limited, and many patients do not receive optimized long-term asthma management. The purpose of this study is to evaluate whether a structured remote asthma clinic intervention initiated shortly after hospital discharge can reduce recurrent exacerbations and improve asthma-related outcomes compared to standard community care. This prospective randomized study will enroll 220 adult patients (18-75 years) presenting to the emergency department at Tel Aviv Sourasky Medical Center with an asthma exacerbation. Participants will be randomly assigned to one of two groups: 1. Intervention group - will undergo two structured remote pulmonology follow-up visits via secure video consultation within 7-21 days and 5 months after discharge, including treatment optimization, inhaler technique assessment, and self-management education. 2. Control group - will continue standard community care without additional intervention. All participants will complete scheduled follow-up assessments over 12 months, including evaluation of exacerbations, asthma control, healthcare utilization, and medication use.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Presentation to the emergency department with an asthma exacerbation. * Ability to complete telephone follow-up and access to a personal e-mail account. * Agreement to participate in the study. * Written or verbal informed consent according to study group assignment. Exclusion Criteria: * Uncontrolled cardiac disease. * Any other uncontrolled medical condition. * Inability to complete telephone follow-up. * Pregnancy. * Patients lacking decision-making capacity.

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-28.